Latest period
5.73B
YoY change
-0.2%
5Y CAGR
+0.2%
Peak year (2010)
8.07B
Latest annual
5.69B
Shares Outstanding history chart for Pfizer (PFE) from 1985 to 2025
Latest: 5.69B
Shares Outstanding growth chart for Pfizer (PFE) from 1985 to 2025
Latest: -0.2%
Shares Outstanding history table for Pfizer (PFE) from 1985 to 2025
| 2025 | 5.69B | -0.2% | -14.00M | ||
| 2024 | 5.70B | -0.2% | -9.00M | ||
| 2023 | 5.71B | -0.4% | -24.00M | ||
| 2022 | 5.73B | +0.4% | +25.00M | ||
| 2021 | 5.71B | +1.3% | +76.00M | ||
| 2020 | 5.63B | -0.8% | -43.00M | ||
| 2019 | 5.67B | -5.1% | -302.00M | ||
| 2018 | 5.98B | -1.3% | -81.00M | ||
| 2017 | 6.06B | -1.6% | -101.00M | ||
| 2016 | 6.16B | -1.6% | -98.00M | ||
| 2015 | 6.26B | -2.6% | -167.00M | ||
| 2014 | 6.42B | -6.8% | -471.00M | ||
| 2013 | 6.89B | -8.2% | -613.00M | ||
| 2012 | 7.51B | -4.6% | -362.00M | ||
| 2011 | 7.87B | -2.5% | -204.00M | ||
| 2010 | 8.07B | +14.6% | +1.03B | ||
| 2009 | 7.04B | +4.4% | +295.00M | ||
| 2008 | 6.75B | -2.7% | -189.00M | ||
| 2007 | 6.94B | -4.6% | -335.00M | ||
| 2006 | 7.27B | -1.8% | -137.00M | ||
| 2005 | 7.41B | -2.7% | -203.00M | ||
| 2004 | 7.61B | +4.5% | +328.00M | ||
| 2003 | 7.29B | +16.7% | +1.04B | ||
| 2002 | 6.24B | -1.9% | -120.00M | ||
| 2001 | 6.36B | -0.1% | -7.00M | ||
| 2000 | 6.37B | +0.8% | +51.00M | ||
| 1999 | 6.32B | +60.4% | +2.38B | ||
| 1998 | 3.94B | -0.3% | -13.29M | ||
| 1997 | 3.95B | +2.4% | +93.79M | ||
| 1996 | 3.86B | +2.2% | +83.04M | ||
| 1995 | 3.77B | +1.5% | +56.39M | ||
| 1994 | 3.72B | -3.9% | -149.08M | ||
| 1993 | 3.87B | -4.6% | -186.85M | ||
| 1992 | 4.05B | +1.1% | +42.83M | ||
| 1991 | 4.01B | +5.1% | +196.43M | ||
| 1990 | 3.82B | -10.4% | -441.64M | ||
| 1989 | 4.26B | +2.2% | +92.14M | ||
| 1988 | 4.16B | +2.6% | +104.74M | ||
| 1987 | 4.06B | -1.6% | -65.00M | ||
| 1986 | 4.13B | -0.4% | -15.71M | ||
| 1985 | 4.14B | — | — |
- 20255.69B-0.2%
- 20245.70B-0.2%
- 20235.71B-0.4%
- 20225.73B+0.4%
- 20215.71B+1.3%
- 20205.63B-0.8%
- 20195.67B-5.1%
- 20185.98B-1.3%
- 20176.06B-1.6%
- 20166.16B-1.6%
- 20156.26B-2.6%
- 20146.42B-6.8%
- 20136.89B-8.2%
- 20127.51B-4.6%
- 20117.87B-2.5%
- 20108.07B+14.6%
- 20097.04B+4.4%
- 20086.75B-2.7%
- 20076.94B-4.6%
- 20067.27B-1.8%
- 20057.41B-2.7%
- 20047.61B+4.5%
- 20037.29B+16.7%
- 20026.24B-1.9%
- 20016.36B-0.1%
- 20006.37B+0.8%
- 19996.32B+60.4%
- 19983.94B-0.3%
- 19973.95B+2.4%
- 19963.86B+2.2%
- 19953.77B+1.5%
- 19943.72B-3.9%
- 19933.87B-4.6%
- 19924.05B+1.1%
- 19914.01B+5.1%
- 19903.82B-10.4%
- 19894.26B+2.2%
- 19884.16B+2.6%
- 19874.06B-1.6%
- 19864.13B-0.4%
- 19854.14B—
Shares Outstanding values are taken from Pfizer's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at Pfizer (PFE)
According to Pfizer's latest reported financial statements, the company's latest reported diluted shares outstanding is 5.73B. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Pfizer (PFE) diluted shares outstanding is 5.69B – edged down 0.2% year-over-year.
Through 2020–2025 (5 years), Pfizer diluted shares outstanding delivered a +0.2% annualised rate; with mixed annual results across the window.
Between 2010 and 2025, Pfizer diluted shares outstanding declined 29.6%, falling from 8.07B to 5.69B.
2010 marks the peak diluted shares outstanding at 8.07B, with the historical low of 3.72B recorded in 1994.
Pfizer Shares Outstanding by Year
Pfizer Shares Outstanding 2025: 5.69B
Pfizer posted diluted shares outstanding of 5.69B in 2025, edged down 0.2% below 2024.
Pfizer Shares Outstanding 2024: 5.70B
In 2024, Pfizer reported diluted shares outstanding of 5.70B, edged down 0.2% below 2023.
Pfizer Shares Outstanding 2023: 5.71B
Pfizer diluted shares outstanding in 2023 was 5.71B, edged down 0.4% below 2022.
Pfizer Shares Outstanding 2022: 5.73B
2022's diluted shares outstanding for Pfizer came in at 5.73B, edged up 0.4% from 2021.
Pfizer Shares Outstanding 2021: 5.71B
Pfizer diluted shares outstanding in 2021 was 5.71B.
See more financial history for Pfizer (PFE).
Sector peers by Shares Outstanding
Healthcare peers of Pfizer (PFE), ranked by their latest diluted shares outstanding
| 4.45B | |
| 2.51B | |
| 2.43B | |
| 1.77B | |
| 1.56B | |
| 910.00M | |
| 898.00M | |
| 542.00M |
- 4.45B
- 2.51B
- 1.77B
- 1.56B
- 910.00M
- 898.00M
- 542.00M
Frequently asked questions
Pfizer (PFE) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation